Ocular Surface Infection Program

About Lxbio Pharmaceuticals

Lxbio Pharmaceuticals is an emerging, private biotech company based in Lisbon, Portugal, operating in the high-growth sectors of antibody and bacteriophage therapies. It is developing a pre-clinical pipeline targeting therapeutic areas with significant unmet needs, including diabetic foot infections, ocular surface infections, atopic dermatitis, respiratory infections, and diabetic retinopathy. The company has made strategic infrastructure investments, inaugurating a dedicated biologics R&D and production unit, and is actively seeking investment to advance its innovative platforms and pipeline programs.

Therapeutic Areas